Biote Corp. (BTMD) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the BioT Second Quarter 2025 Earnings Conference Call. Today, all participants will be in a listen-only mode. Should you need assistance during today's call, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note that today's event is being recorded. I would now like to turn the conference over to Simon Sarovetsky, Investor Relations. Please go ahead. Thank you for joining us today. This afternoon, Biotech published financial results for the second quarter in the June 30, 2025. This news release is available in the Investor Relations section of the company's website. Hosting today's call are Bert Christensen, Chief Executive Officer, Bob Peterson, Chief Financial Officer, and Mark Beer, Executive Chairman. Before we get started, I'd like to remind everyone that manager-owning statements are in this call. That includes forward-looking statements regarding, among other things, the company's financial results, future performance and growth opportunities, business outlook, strategies, goals, research and development, manufacturing and commercialization activities, competitive position, regulatory process operations, benefits of its solutions, anticipated impact of macroeconomic conditions on its business, rules of operations, management conditions, and other matters that do not relate to historical facts. These statements are not guarantees of future performance. They are subject to a variety of risks and uncertainties, some of which are beyond the company's control. Actual results could differ materially from ...